Department of Public Health Sciences


Postdoctoral training, Molecular Epidemiology, Division of Infectious Diseases and Geographic Medicine, Stanford University
PhD, Epidemiology, University of California, Berkeley
MPH, Biostatistics/Epidemiology, University of California, Berkeley
MS, Zoology, University of Washington
BSc with Distinction, Biology, Stanford University

Courses Taught
EPI-231:  Infectious Disease Epidemiology
EPI-206:  Epidemiologic Study Designs
EPI-299:  Independent Research
FRS-001-006:  Global Health Challenges
IDI/SPH-211:  Prevention and Control of Infectious Diseases
MMI-480B:  Pathogenic Microbiology (Lecturer)
MMI-199/299:  Independent Research

Professional Affiliations/Awards
NIH Director's New Innovator Award, 2010-2015
Director, UC Davis-China Infectious Diseases Research Training Program, 2008-2014
Pfizer Scholars Grant in Public Health, 2006-2009
International Research Scientist Development Award (IRSDA), Fogarty International Center (FIC), National Institutes of Health (NIH), 2000-2006
Fulbright-Hays Doctoral Dissertation Research Fellow in Brazil, 1997-1998
InterAmerican Foundation (IAF) Doctoral Research Fellow in Brazil, 1996-1997
Graduate Division Fellowship, UC Berkeley, 1996 and 1999
Member, Graduate Group in Epidemiology (GGE)
Member, Microbiology Graduate Group (MGG)

Selected Publications
  1. Luo T, Yang C, Peng Y, Lu L, Sun G, Wu J, Jin X, Hong J, Li F, Mei J, DeRiemer K, Gao Q. (2014). Whole genome sequencing to detect recent transmission of Mycobacterium tuberculosis in settings with a high burden of tuberculosis. Tuberculosis (Edinb.), 94(4):434-40.

  2. DeRiemer K, on behalf of the Collaborative Group for Meta-Analysis of MDR-TB. (2014). Meta-Analysis. In: The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS: Challenges and Opportunities: Summary of a Joint Workshop. Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences. Washington, DC. The National Academies Press.

  3. Stopka TJ, Geraghty EM, Azari R, Gold EB, DeRiemer K. (2014). Is crime associated with over-the-counter pharmacy syringe sales? Findings from Los Angeles, California. Int J Drug Policy, 25(2):244-50.

  4. Chen J, Qi L, Xia Z, Shen M, Shen X, Mei J, DeRiemer K, Yuan Z. (2013). Which urban migrants default from treatment in Shanghai, China? PLoS ONE, 8(11):e81351.

  5. Gehre F, Otu J, DeRiemer K, Sessions PF, Hibberd ML, Mulders W, Corrah T, de Jong B, Antonio M. (2013). Deciphering the growth behaviour of Mycobacterium africanum. PLoS Negl Trop Dis, 7(5):e2220.

  6. Falzon D1, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. (2013). Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J, 42(1):156-68.

  7. Shen X, Xia Z, Li X, Wu J, Wang L, Li J, Jiang Y, Guo J, Chen J, Hong J, Yuan Z, Pan Q, DeRiemer K, Sun G, Mei J, Gao Q. (2012). Tuberculosis in an urban area in China: differences between urban migrants and local residents. PLoS ONE, 7(11):e51133.

  8. Yang C, Luo T, Sun G, Qiao Ke, Sun G, DeRiemer K, Mei J, Gao Q. (2012). The Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China. Clin Infect Dis, 55(9):1179-1187.

  9. Stopka TJ, Lutnick A, Wenger LD, DeRiemer K, Geraghty EM, Kral AH. (2012). Demographic, risk and spatial factors associated with over-the-counter syringe purchase among injection drug users. Am J Epidemiol, 176(1):14-23.

  10. Abernethy NF, DeRiemer K, Small PM. (2011). Methods to Identify Standard Data Elements in Clinical and Public Health Forms. American Medical Informatics Association (AMIA). Ann Symp Proc,:19-27.

  11. Pascopella L, DeRiemer K, Watt JP, Flood JM. (2011). When tuberculosis comes back: who develops recurrent tuberculosis in California? PloS ONE , 6(11):e26541.

  12. de Jong BC, Hill PC, Aiken A, Awine T, Antonio M, Adetifa IM, Jackson-Sillah DJ, Fox A, DeRiemer K, Gagneux S, Borgdorff MW, McAdam KP, Corrah T, Small PM, Adegbola RA. (2008). Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis, 198(7):1037-1043.

  13. DeRiemer K, Kawamura LM, Hopewell PC, Daley CL. (2007). Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med , 176(9):936-44.

  14. Dickert N, DeRiemer K, Duffy PE, Garcia-Garcia L, Mutabingwa TK, Sina BJ, Tindana P, Lie R. (2007). Ancillary-care responsibilities in observational research: two cases, two issues. Lancet, 369(9564):874-7.

  15. Reed MB, Gagneux S, DeRiemer K, Small PM, Barry, CE 3rd. (2007). The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol, 189(7):2583-9.

  16. Li X, Zhang Y, Shen X, Shen G, Gui X, Sun B, Mei J, DeRiemer K, Small PM, Gao Qz. (2007). Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J Infect Dis, 195(6):864-9.

  17. Gagneux S, Burgos MV, DeRiemer K, Enciso A, Muñoz S, Hopewell PC, Small PM, Pym AS. (2006). Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathogens, 2(6):e61.

  18. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM. (2006). Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA, 103(8):286973.

  19. DeRiemer K, Garcia-Garcia ML, Bobadilla-del-Valle M, Palacios-Martinez M, Martinez-Gamboa A, Small PM, Sifuentes-Osornio J, Ponce-de-León A. (2005). Does DOTS work in populations with drug resistant tuberculosis? Lancet , 365(9466):1239-45.

  20. DeRiemer K, Daley CL. (2004). Tuberculosis transmission based on molecular epidemiologic research. Semin Respir Crit Care Med, 25(3):297-306.

  21. Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM. (2004). Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci USA, 101(14):4871-6.

  22. Tsolaki AG, Hirsh AE, DeRiemer K, Enciso JA, Wong MZ, Hannan M, Goguet de la Salmoniere YO, Aman K, Kato-Maeda M, Small PM. (2004). Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc Natl Acad Sci USA, 101(14):4865-70.

  23. DeRiemer K, Small PM. (2004). What is molecular epidemiology and what is its role in tuberculosis control? In: Frieden T, editor. Toman's tuberculosis case-detection, treatment, and monitoring: questions and answers. Geneva: World Health Organization, 2nd edition:296-300. WHO/HTM/TB/2004.334.

  24. DeRiemer K, Daley CL. (2004). Molecular Epidemiology of Tuberculosis. In: Madkour MM, editor. Tuberculosis. Heidelberg: Springer Verlag,:57-74.

  25. Burgos M, DeRiemer K, Small PM, Hopewell PC, Daley CL. (2003). Effect of drug-resistance on the generation of secondary cases of tuberculosis. J Infect Dis , 188(12):1878-84.

  26. Carvalho AC, DeRiemer K, Nunes ZB, Martins M, Comelli M, Marinoni A, Kritski AL. (2001). Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis. Am J Respir Crit Care Med, 164(12):2166-71.

  27. DeRiemer K, Soares EC, Dias SM, Cavalcante SC. (2000). HIV testing among tuberculosis patients in the era of antiretroviral therapy: a population-based study in Brazil. Int J Tuberc Lung Dis, 4(6):519-27.

  28. Chin DP, DeRiemer K, Small PM, de Leon AP, Steinhart R, Schecter GF, Daley CL, Moss AR, Paz EA, Jasmer RM, Agasino CB, Hopewell PC. (1998). Differences in contributing factors to tuberculosis incidence in U.S.-born and foreign-born persons. Am J Respir Crit Care Med, 158(6):1797-803.